Getting Competition Down to a Science: The Effects of Technological Competition on Firms' Scientific Publications

Francisco Polidoro () and Matt Theeke ()
Additional contact information
Francisco Polidoro: McCombs School of Business, University of Texas at Austin, Austin, Texas 78712
Matt Theeke: McCombs School of Business, University of Texas at Austin, Austin, Texas 78712

Organization Science, 2012, vol. 23, issue 4, 1135-1153

Abstract: Prior research about the interaction between private firms and the scientific community has largely viewed firms' articles in scientific publications as a means to improve research and development productivity—by encouraging their researchers to publish scientific papers, firms can maintain linkages with the scientific community, attract talent, and access external knowledge on which they can build to create innovations. This paper, in contrast, emphasizes the role of scientific publications in firms' battles for market dominance and examines how competitive conditions shape firms' propensities to publish scientific articles about their innovations. Focusing on the context of pharmaceutical drugs, we develop propositions about how the competition that one drug faces from similar drugs and potential substitutes influences the innovating firm's inclination to publish articles in the top medical journals about that drug to facilitate its assessment by the U.S. Food and Drug Administration and the medical community. We also propose that scientific articles about competing drugs compel a firm to highlight its own drug in scientific papers to assert the drug's uniqueness and mitigate the threat of substitution. Whereas prior research has elucidated how science contributes to enhancing firms' competence at creating innovations, which is critical to their ability to compete in technology-intensive environments, this paper draws attention to how competition, in turn, permeates into the scientific arena, creating inducements for firms to use scientific publications to position their innovations in the marketplace.

Keywords: innovations; knowledge-based competitive advantage; technological competition; imitation; substitution; scientific community; scientific publications; pharmaceutical drugs; top medical journals (search for similar items in EconPapers)
Date: 2012
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (30)

Downloads: (external link)
http://dx.doi.org/10.1287/orsc.1110.0684 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:inm:ororsc:v:23:y:2012:i:4:p:1135-1153

Access Statistics for this article

More articles in Organization Science from INFORMS Contact information at EDIRC.
Bibliographic data for series maintained by Chris Asher ().